Literature DB >> 25903853

Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis.

Gaya Spolverato1, Hadia Maqsood, Alessandro Vitale, Sorin Alexandrescu, Hugo P Marques, Luca Aldrighetti, T Clark Gamblin, Carlo Pulitano, Todd W Bauer, Feng Shen, George Poultsides, Shishir Maithel, J Wallis Marsh, Timothy M Pawlik.   

Abstract

BACKGROUND: The objective of the current study was to define the incidence of 30-day readmission after hepatic resection for intrahepatic cholangiocarcinoma (ICC). In particular, we sought to identify risk factors associated with a higher risk of readmission among patients undergoing resection for ICC.
METHODS: Patients who underwent hepatic resection for ICC at 12 major hepatobiliary centers in the USA, Europe, Australia, and Asia between 1990 and 2013 were identified. Thirty-day readmission and clinicopathologic characteristics associated with higher risk of readmission were examined.
RESULTS: Among 602 patients, 401 (68.3%) patients underwent a major hepatectomy and 256 (43.3%) experienced at least one post-operative complication. Overall 30-day readmission was 7.8% (n = 47). Risk factors associated with readmission included pre-operative jaundice (odds ratio (OR) 2.45) and the presence of a major complication (OR 3.38). In fact, 95.7% of readmitted patients had experienced a post-operative complication versus only 38.8% of non-readmitted patients (P < 0.001). Among patients who were readmitted, repeat hospitalization was associated with a median LOS of 6.5 days (interquartile range (IQR) 4.0-11.5) and one patient died during readmission.
CONCLUSIONS: Readmission after hepatic resection for ICC occurred in 1 in 13 patients. Patients with pre-operative jaundice and those who experienced a complication had over a threefold higher risk of being readmitted.

Entities:  

Mesh:

Year:  2015        PMID: 25903853     DOI: 10.1007/s11605-015-2826-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  32 in total

Review 1.  Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature.

Authors:  Murad Aljiffry; Alhawsawi Abdulelah; Mark Walsh; Kevork Peltekian; Ian Alwayn; Michele Molinari
Journal:  J Am Coll Surg       Date:  2008-10-31       Impact factor: 6.113

2.  Rehospitalizations among patients in the Medicare fee-for-service program.

Authors:  Stephen F Jencks; Mark V Williams; Eric A Coleman
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

Review 3.  Intrahepatic cholangiocarcinoma: management options and emerging therapies.

Authors:  Rebecca M Dodson; Matthew J Weiss; David Cosgrove; Joseph M Herman; Ihab Kamel; Robert Anders; Jean-Francois H Geschwind; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-07-24       Impact factor: 6.113

4.  Risk factors for 30-day hospital readmission after thyroidectomy and parathyroidectomy in the United States: An analysis of National Surgical Quality Improvement Program outcomes.

Authors:  Matthew G Mullen; Damien J LaPar; Sara K Daniel; Florence E Turrentine; John B Hanks; Philip W Smith
Journal:  Surgery       Date:  2014-11-11       Impact factor: 3.982

5.  Determinants of 30-d readmission after colectomy.

Authors:  Afif N Kulaylat; Peter W Dillon; Christopher S Hollenbeak; David B Stewart
Journal:  J Surg Res       Date:  2014-09-30       Impact factor: 2.192

6.  Readmissions after major urologic cancer surgery.

Authors:  Jeffrey J Leow; Giorgio Gandaglia; Akshay Sood; Nedim Ruhotina; Dane E Klett; Jesse D Sammon; Marianne Schmid; Maxine Sun; Steven L Chang; Adam S Kibel; Quoc-Dien Trinh
Journal:  Can J Urol       Date:  2014-12       Impact factor: 1.344

7.  Factors predictive of readmission after hepatic resection for hepatocellular carcinoma.

Authors:  Charles W Kimbrough; Steven C Agle; Charles R Scoggins; Robert C G Martin; Michael R Marvin; Eric G Davis; Kelly M McMasters; Christopher M Jones
Journal:  Surgery       Date:  2014-07-30       Impact factor: 3.982

8.  Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies.

Authors:  Eric B Schneider; Omar Hyder; Christopher L Wolfgang; Kenzo Hirose; Michael A Choti; Martin A Makary; Joseph M Herman; John L Cameron; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2012-08-24       Impact factor: 6.113

9.  Time-to-readmission and Mortality After High-risk Surgery.

Authors:  Andrew A Gonzalez; Zaid M Abdelsattar; Justin B Dimick; Shantanu Dev; John D Birkmeyer; Amir A Ghaferi
Journal:  Ann Surg       Date:  2015-07       Impact factor: 12.969

10.  Readmission after lung cancer resection is associated with a 6-fold increase in 90-day postoperative mortality.

Authors:  Yinin Hu; Timothy L McMurry; James M Isbell; George J Stukenborg; Benjamin D Kozower
Journal:  J Thorac Cardiovasc Surg       Date:  2014-04-18       Impact factor: 5.209

View more
  3 in total

1.  Possible Preventable Causes of Unplanned Readmission After Elective Liver Resection, Results from a Non-academic Referral HPB Center.

Authors:  G W de Klein; R M Brohet; M S L Liem; J M Klaase
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

2.  Timing and severity of post-discharge morbidity after hepatectomy.

Authors:  Mustafa Raoof; Aaron Lewis; Leanne Goldstein; Sinziana Dumitra; Susanne G Warner; Gagandeep Singh; Yuman Fong; Laleh Melstrom
Journal:  HPB (Oxford)       Date:  2017-01-26       Impact factor: 3.647

3.  Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma.

Authors:  Javier Valero-Elizondo; Yuhree Kim; Jason D Prescott; Georgios A Margonis; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Jason A Glenn; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-08-19       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.